GSK (GSK) plans to depart the biotechnology industry’s largest trade group, the Biotechnology Innovation Organization, STAT’s John Wilkerson, Lizzy Lawrence, Rachel Cohrs Zhang, and Sarah Owermohle ...

Blenrep, Depemokimab, Nucala for COPD, Gepotidacin, and our new vaccine to prevent meningitis (MenABCWY).' Sheena Berry, an analyst at Quilter Cheviot, said: 'GSK’s third quarter results for ...

Drugmaker GSK saw a sharp drop in revenue from its blockbuster ... five major new product approval opportunities next year.” Blenrep, a treatment for cancer, and asthma medicine Depemokimab ...

Drugmaker GSK saw a sharp drop in revenue from its blockbuster Arexvy ... planning launches for five major new product approval opportunities next year.” Blenrep, a treatment for cancer, and asthma ...